In its December 13 issue, the Journal of the American Medical Association published a letter from the Society of Cannabis Clinicians exposing duplicity on the part of the Federation of State Medical Boards —along with a duplicitous reply by FSMB president and CEO Humayon Chaudhry, DO.
The SCC letter was written in response to a “Viewpoint” op-ed by Chaudhry entitled “Medical Board Expectations for Physicians Recommending Marijuana,” published online June 22 and in the print edition of JAMA August 9.
The SCC opposes several key provisions in the “model guidelines” the Federation wants the state medical boards to adopt. These provisions would:
• trigger investigations of cannabis clinicians based on how many patients they approve and how many plants they authorize patients to grow.
• constrain cannabis clinicians from using cannabis as medicine themselves.
• prevent cannabis clinicians from conducting research in concert with dispensaries.
Dr. Chaudhry addressed the last point in his reply:
“The FSMB model guidelines do not prohibit and are not meant toimpede physician association with dispensaries for researchpurposes. The policy states: ‘A physician who recommendsmarijuana should not have a professional office located at adispensary or cultivation center or receive financial compen-sation from or hold a financial interest in a dispensary or cul-tivation center. Nor should the physician be a director, offi-cer, member, incorporator, agent, employee, or retailer of adispensary or cultivation center.'”
Our Viewpoint was not intended as a substitute for the model guidelines, but as a general summary.
A summary is supposed to make a document more succinct —not to conceal or reverse its meaning.
Flash forward to 2016 and the Federation is pushing “model guidelines” that would constrain physicians from prescribing cannabis. Who is funding the present effort? Details TK.